Helicobacter pylori Infection Does Not Impact on Lung Transplant Outcome

Lung. 2019 Feb;197(1):95-99. doi: 10.1007/s00408-018-0178-7. Epub 2018 Nov 19.

Abstract

Background: Helicobacter pylori (HP) is a spiral, gram-negative, microaerophilic bacterium that colonises the human gastric mucosa and is associated with gastrointestinal and extragastrointestinal disorders. Since no data are yet available on HP infection in lung transplant patients, we evaluated the prevalence and impact of HP infection in a population of such patients.

Methods: Sixty-seven lung transplant patients were enrolled in the study (35 females and 32 males, age 48.4 ± 13.3 years), 54 underwent bilateral and 13 single lung transplant. Serum antibodies against HP and CagA were assayed in all subjects.

Results: The prevalence of HP infection in lung transplant patients was similar to that in the general population (49.25% vs. 51.4%), whereas HP-positive patients showed lower CagA positivity (9% vs. 50.2%, p < 0.0001). There was a higher prevalence of HP infection in patients who underwent lung transplant because of pulmonary fibrosis (p = 0.049), and a lower prevalence in COPD patients (p = 0.011). No correlation was found between HP infection in lung transplant patients and graft outcome. No differences in primary graft dysfunction, acute rejection or bronchiolitis obliterans syndrome-free survival were found. However, more patients who required three or more post-transplant re-hospitalisations were observed among HP-positive patients.

Conclusions: The prevalence of HP infection in lung transplant patients was comparable to that of the general population and to that reported in heart and kidney transplant recipients. It did not seem to impact short-, mid- or long-term lung allograft outcome. H. pylori infection did not prove to be clinically relevant in lung transplant patients.

Keywords: Epidemiology; Helicobacter pylori; Lung transplantation.

MeSH terms

  • Adult
  • Female
  • Helicobacter Infections / diagnosis
  • Helicobacter Infections / epidemiology
  • Helicobacter Infections / microbiology*
  • Helicobacter pylori / pathogenicity*
  • Humans
  • Italy / epidemiology
  • Lung Diseases / diagnosis
  • Lung Diseases / epidemiology
  • Lung Diseases / surgery*
  • Lung Transplantation* / adverse effects
  • Male
  • Middle Aged
  • Patient Readmission
  • Postoperative Complications / epidemiology
  • Postoperative Complications / therapy
  • Prevalence
  • Risk Factors
  • Time Factors
  • Treatment Outcome